v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Ordinary Shares Issued
Treasury Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Shares issued at the beginning of period (in shares) at Dec. 31, 2024   1,387,367,704        
Shares, issues, treasury stock at the beginning of period (in shares) at Dec. 31, 2024 [1]     0      
Shares outstanding at the beginning of period (in shares) at Dec. 31, 2024   1,387,367,704        
Balance at the beginning of period at Dec. 31, 2024 $ 3,332,222 $ 138   $ 12,087,908 $ (148,988) $ (8,606,836)
Increase (Decrease) in Stockholders' Equity            
Issuance of shares reserved for share option exercises (in shares)   402,532        
Issuance of shares reserved for share option exercises (in shares)   402,532        
Exercise of options, ESPP and release of RSUs (in shares)   15,511,587        
Exercise of options, ESPP and release of RSUs 63,876 $ 2   63,874    
Share-based compensation 95,478     95,478    
Other comprehensive income 6,667       6,667  
Net income 1,270         1,270
Shares issued at the end of period (in shares) at Mar. 31, 2025   1,403,281,823        
Shares, issues, treasury stock at the end of the period (in shares) at Mar. 31, 2025 [1]     0      
Shares outstanding at the end of period (in shares) at Mar. 31, 2025   1,403,281,823        
Balance at the end of period at Mar. 31, 2025 3,499,513 $ 140   12,247,260 (142,321) (8,605,566)
Shares issued at the beginning of period (in shares) at Dec. 31, 2024   1,387,367,704        
Shares, issues, treasury stock at the beginning of period (in shares) at Dec. 31, 2024 [1]     0      
Shares outstanding at the beginning of period (in shares) at Dec. 31, 2024   1,387,367,704        
Balance at the beginning of period at Dec. 31, 2024 3,332,222 $ 138   12,087,908 (148,988) (8,606,836)
Increase (Decrease) in Stockholders' Equity            
Net income 220,431          
Shares issued at the end of period (in shares) at Sep. 30, 2025   1,540,975,898        
Shares, issues, treasury stock at the end of the period (in shares) at Sep. 30, 2025 [1]     (102,892,308)      
Shares outstanding at the end of period (in shares) at Sep. 30, 2025   1,438,083,590        
Balance at the end of period at Sep. 30, 2025 4,129,326 $ 144   12,616,844 (101,257) (8,386,405)
Shares issued at the beginning of period (in shares) at Mar. 31, 2025   1,403,281,823        
Shares, issues, treasury stock at the beginning of period (in shares) at Mar. 31, 2025 [1]     0      
Shares outstanding at the beginning of period (in shares) at Mar. 31, 2025   1,403,281,823        
Balance at the beginning of period at Mar. 31, 2025 3,499,513 $ 140   12,247,260 (142,321) (8,605,566)
Increase (Decrease) in Stockholders' Equity            
Issuance of shares reserved for share option exercises (in shares)   109,306,902        
Issuance of shares reserved for share option exercises (in shares) [1]     (112,772,594)      
Issuance of shares reserved for share option exercises (in shares)   (3,465,692)        
Exercise of options, ESPP and release of RSUs (in shares)   28,387,173        
Exercise of options, ESPP and release of RSUs 32,733 $ 3   32,730    
Share-based compensation 150,809     150,809    
Withholding taxes from share-based awards (35,523)     (35,523)    
Other comprehensive income 28,623       28,623  
Net income 94,320         94,320
Shares issued at the end of period (in shares) at Jun. 30, 2025   1,540,975,898        
Shares, issues, treasury stock at the end of the period (in shares) at Jun. 30, 2025 [1]     (112,772,594)      
Shares outstanding at the end of period (in shares) at Jun. 30, 2025   1,428,203,304        
Balance at the end of period at Jun. 30, 2025 3,770,475 $ 143   12,395,276 (113,698) (8,511,246)
Increase (Decrease) in Stockholders' Equity            
Exercise of options, ESPP and release of RSUs (in shares) [1]     9,880,286      
Exercise of options, ESPP and release of RSUs (in shares)   9,880,286        
Exercise of options, ESPP and release of RSUs 80,760 $ 1   80,759    
Share-based compensation 140,809     140,809    
Other comprehensive income 12,441       12,441  
Net income 124,841         124,841
Shares issued at the end of period (in shares) at Sep. 30, 2025   1,540,975,898        
Shares, issues, treasury stock at the end of the period (in shares) at Sep. 30, 2025 [1]     (102,892,308)      
Shares outstanding at the end of period (in shares) at Sep. 30, 2025   1,438,083,590        
Balance at the end of period at Sep. 30, 2025 $ 4,129,326 $ 144   12,616,844 (101,257) (8,386,405)
Shares issued at the beginning of period (in shares) at Dec. 31, 2025 1,540,975,898 1,540,975,898        
Shares, issues, treasury stock at the beginning of period (in shares) at Dec. 31, 2025 [1]     (99,900,280)      
Shares outstanding at the beginning of period (in shares) at Dec. 31, 2025 1,441,075,618 1,441,075,618        
Balance at the beginning of period at Dec. 31, 2025 $ 4,361,194 $ 144   12,759,137 (78,184) (8,319,903)
Increase (Decrease) in Stockholders' Equity            
Exercise of options, ESPP and release of RSUs (in shares) [1]     3,403,760      
Exercise of options, ESPP and release of RSUs (in shares)   3,403,760        
Exercise of options, ESPP and release of RSUs 23,834     23,834    
Share-based compensation 123,355     123,355    
Other comprehensive income 24,702       24,702  
Net income 227,357         227,357
Shares issued at the end of period (in shares) at Mar. 31, 2026   1,540,975,898        
Shares, issues, treasury stock at the end of the period (in shares) at Mar. 31, 2026 [1]     (96,496,520)      
Shares outstanding at the end of period (in shares) at Mar. 31, 2026   1,444,479,378        
Balance at the end of period at Mar. 31, 2026 $ 4,760,442 $ 144   12,906,326 (53,482) (8,092,546)
Shares issued at the beginning of period (in shares) at Dec. 31, 2025 1,540,975,898 1,540,975,898        
Shares, issues, treasury stock at the beginning of period (in shares) at Dec. 31, 2025 [1]     (99,900,280)      
Shares outstanding at the beginning of period (in shares) at Dec. 31, 2025 1,441,075,618 1,441,075,618        
Balance at the beginning of period at Dec. 31, 2025 $ 4,361,194 $ 144   12,759,137 (78,184) (8,319,903)
Increase (Decrease) in Stockholders' Equity            
Other comprehensive income 71,573          
Net income $ 849,070          
Shares issued at the end of period (in shares) at Sep. 30, 2026 1,541,841,971 1,541,841,971        
Shares, issues, treasury stock at the end of the period (in shares) at Sep. 30, 2026 [1]     (58,523,936)      
Shares outstanding at the end of period (in shares) at Sep. 30, 2026 1,483,318,035 1,483,318,035        
Balance at the end of period at Sep. 30, 2026 $ 5,820,394 $ 148   13,297,690 (6,611) (7,470,833)
Shares issued at the beginning of period (in shares) at Mar. 31, 2026   1,540,975,898        
Shares, issues, treasury stock at the beginning of period (in shares) at Mar. 31, 2026 [1]     (96,496,520)      
Shares outstanding at the beginning of period (in shares) at Mar. 31, 2026   1,444,479,378        
Balance at the beginning of period at Mar. 31, 2026 4,760,442 $ 144   12,906,326 (53,482) (8,092,546)
Increase (Decrease) in Stockholders' Equity            
Exercise of options, ESPP and release of RSUs (in shares) [1]     24,799,437      
Exercise of options, ESPP and release of RSUs (in shares)   24,799,437        
Exercise of options, ESPP and release of RSUs 11,032 $ 3   11,029    
Share-based compensation 137,405     137,405    
Other comprehensive income 28,112       28,112  
Net income 237,007         237,007
Shares issued at the end of period (in shares) at Jun. 30, 2026   1,540,975,898        
Shares, issues, treasury stock at the end of the period (in shares) at Jun. 30, 2026 [1]     (71,697,083)      
Shares outstanding at the end of period (in shares) at Jun. 30, 2026   1,469,278,815        
Balance at the end of period at Jun. 30, 2026 5,173,998 $ 147   13,054,760 (25,370) (7,855,539)
Increase (Decrease) in Stockholders' Equity            
Issuance of shares reserved for share option exercises (in shares)   866,073        
Exercise of options, ESPP and release of RSUs (in shares) [1]     13,173,147      
Exercise of options, ESPP and release of RSUs (in shares)   13,173,147        
Exercise of options, ESPP and release of RSUs 110,444 $ 1   110,443    
Share-based compensation 132,487     132,487    
Other comprehensive income 18,759       18,759  
Net income $ 384,706         384,706
Shares issued at the end of period (in shares) at Sep. 30, 2026 1,541,841,971 1,541,841,971        
Shares, issues, treasury stock at the end of the period (in shares) at Sep. 30, 2026 [1]     (58,523,936)      
Shares outstanding at the end of period (in shares) at Sep. 30, 2026 1,483,318,035 1,483,318,035        
Balance at the end of period at Sep. 30, 2026 $ 5,820,394 $ 148   $ 13,297,690 $ (6,611) $ (7,470,833)
[1] Upon effectiveness of the Continuation, ordinary shares (including in the form of ADS) held by the Company or one of its controlled subsidiaries immediately prior to the effective date of the Continuation became part of the Company’s issued but not outstanding share capital and are considered ordinary shares of the Company, or “treasury shares” under Swiss law. The Company expects to use these treasury shares in the future to satisfy obligations to deliver shares in connection with awards granted under the Company’s equity incentive plans and agreements.